Literature DB >> 22631448

Inhibition of UVB-induced oxidative damage and apoptotic biochemical changes in human lymphocytes by 2,5-dihydroxy-3-undecyl-1,4-benzoquinone (embelin).

Narayanaswamy Radhakrishnan1, Arumugam Gnanamani, Nagarajan Rajendra Prasad, Asit Baran Mandal.   

Abstract

PURPOSE: The present study investigates the inhibition of Ultraviolet B (UVB, 290-320 nm) radiation-induced oxidative damage in peripheral blood human lymphocytes by embelin extracted from Embelia ribes.
MATERIALS AND METHODS: Embelin was extracted, purified and characterized. Prior to inhibitory assessment, a maximum concentration of embelin that was non-toxic was determined. Six experimental groups, including respective controls were made to assess the inhibitory effect of embelin for the selected concentrations of 10 and 20 μg/ml. For the experimental groups; lymphocytes (1 × 10(6) cells) were pre-treated with the chosen concentration of embelin for a period of 60 min and then exposed to UVB for 30 min. UVB radiation inhibitory effect of embelin assessed by measuring antioxidant and lipid peroxidation levels, deoxyribonucleic acid (DNA) damage, reactive oxygen species (ROS) and mitochondrial membrane potential (MMP) at scheduled time points after irradiation.
RESULTS: Pre-treatment of lymphocytes with embelin prevents UVB-induced oxidative damage. An increase in antioxidant levels in irradiated cells in the presence of embelin and UV absorbance of embelin could be the reason for the decrease in lipid peroxidation level and prevention of DNA damage by UVB radiation.
CONCLUSION: Embelin prevents oxidative stress induced by UVB irradiation via its antioxidant property.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22631448     DOI: 10.3109/09553002.2012.697644

Source DB:  PubMed          Journal:  Int J Radiat Biol        ISSN: 0955-3002            Impact factor:   2.694


  4 in total

1.  Inhibition of Angiogenesis and Nitric Oxide Synthase (NOS), by Embelin & Vilangin Using in vitro, in vivo & in Silico Studies.

Authors:  Radhakrishnan Narayanaswamy; Majumder Shymatak; Suvro Chatterjee; Lam Kok Wai; Gnanamani Arumugam
Journal:  Adv Pharm Bull       Date:  2014-12-31

2.  Potential role of embelin in the prevention of Freund's adjuvant induced inflammation and ROS.

Authors:  H M Kumaraswamy; V Krishna; R Sharath; N D Satyanarayan; P Meghana; R Sandeep Kumar Jain; N Prashanth; H Raja Naika
Journal:  3 Biotech       Date:  2021-12-08       Impact factor: 2.406

3.  Pharmacological evaluation of embelin - chitosan nanoparticles as an antidiabetic agent.

Authors:  Saba Maanvizhi; Narayanaswamy Radhakrishnan; Chitra Krishnan; Arumugam Gnanamani
Journal:  Indian J Pharmacol       Date:  2022 Mar-Apr       Impact factor: 2.833

Review 4.  Plant Derived Phytocompound, Embelin in CNS Disorders: A Systematic Review.

Authors:  Uday P Kundap; Saatheeyavaane Bhuvanendran; Yatinesh Kumari; Iekhsan Othman; Mohd Farooq Shaikh
Journal:  Front Pharmacol       Date:  2017-02-27       Impact factor: 5.810

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.